Loading...
Keywords
Last Name
Institution
 Back to Details

Connection

Craig Friesen to Intestinal Mucosa

This is a "connection" page, showing publications Craig Friesen has written about Intestinal Mucosa.

 
Connection Strength
  
 
 
3.614
  
  1. Singh V, Singh M, Friesen CA. Colonic mucosal eosinophilia in children without inflammatory bowel disease. Hum Pathol. 2021 07; 113:34-38.
    View in: PubMed
    Score: 0.759
  2. Singh M, Singh V, Schurman JV, Colombo JM, Friesen CA. The relationship between mucosal inflammatory cells, specific symptoms, and psychological functioning in youth with irritable bowel syndrome. Sci Rep. 2020 07 20; 10(1):11988.
    View in: PubMed
    Score: 0.721
  3. Singh M, Singh V, Friesen CA. Colonic mucosal inflammatory cells in children and adolescents with lactase deficiency. Pathol Res Pract. 2020 Jun; 216(6):152971.
    View in: PubMed
    Score: 0.708
  4. Singh V, Singh M, Schurman JV, Friesen CA. Histopathological changes in the gastroduodenal mucosa of children with functional dyspepsia. Pathol Res Pract. 2018 Aug; 214(8):1173-1178.
    View in: PubMed
    Score: 0.625
  5. Friesen CA, Andre L, Garola R, Hodge C, Roberts C. Activated duodenal mucosal eosinophils in children with dyspepsia: a pilot transmission electron microscopic study. J Pediatr Gastroenterol Nutr. 2002 Sep; 35(3):329-33.
    View in: PubMed
    Score: 0.209
  6. Colombo JM, Deacy AD, Schurman JV, Friesen CA. Heartburn in children and adolescents in the presence of functional dyspepsia and/or irritable bowel syndrome correlates with the presence of sleep disturbances, anxiety, and depression. Medicine (Baltimore). 2021 Apr 02; 100(13):e25426.
    View in: PubMed
    Score: 0.189
  7. Schurman JV, Singh M, Singh V, Neilan N, Friesen CA. Symptoms and subtypes in pediatric functional dyspepsia: relation to mucosal inflammation and psychological functioning. J Pediatr Gastroenterol Nutr. 2010 Sep; 51(3):298-303.
    View in: PubMed
    Score: 0.091
  8. Friesen CA, Neilan NA, Schurman JV, Taylor DL, Kearns GL, Abdel-Rahman SM. Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics. BMC Gastroenterol. 2009 May 11; 9:32.
    View in: PubMed
    Score: 0.083
  9. Friesen CA, Sandridge L, Andre L, Roberts CC, Abdel-Rahman SM. Mucosal eosinophilia and response to H1/H2 antagonist and cromolyn therapy in pediatric dyspepsia. Clin Pediatr (Phila). 2006 Mar; 45(2):143-7.
    View in: PubMed
    Score: 0.066
  10. Friesen CS, Shakhnovich V, Toren P, Retke B, Schurman J, Colombo J, Deacy A, Friesen CA, Abdel-Rahman S. A Pilot Study of Ketotifen in Patients Aged 8-17 Years with Functional Dyspepsia Associated with Mucosal Eosinophilia. Paediatr Drugs. 2024 Jul; 26(4):451-457.
    View in: PubMed
    Score: 0.059
  11. Friesen CA, Kearns GL, Andre L, Neustrom M, Roberts CC, Abdel-Rahman SM. Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia. J Pediatr Gastroenterol Nutr. 2004 Mar; 38(3):343-51.
    View in: PubMed
    Score: 0.058
  12. Friesen HJ, Rosen J, Low Kapalu C, Singh M, Spaeth T, Cocjin JT, Friesen CA, Schurman JV. Mucosal eosinophils, mast cells, and intraepithelial lymphocytes in youth with rumination syndrome. Neurogastroenterol Motil. 2021 10; 33(10):e14155.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.